Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Ra Capital Management, L.P. reported a 9.40% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Ra Capital Management, L.P. reported a 9.40% stake in Dianthus Therapeutics, Inc., 2,866,733 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 2,866,733
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.40% | 2,866,733 |
| Peter Kolchinsky | 9.40% | 2,866,733 |
| Rajeev Shah | 9.40% | 2,866,733 |
| RA Capital Healthcare Fund, L.P. | 9.40% | 2,866,733 |
Source
Related
- Dianthus Therapeutics, Inc.
- Ra Capital Management, L.P.
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Nov 14, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2025
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026